Editorials and News on Asbestos

PubMed, the National Library of Medicine's index of medical journals, labels every article with its publication type. 389 studies in our library are labeled as editorials and news items published in medical journals. The labels are NLM's, not ours. Each entry links to the study on PubMed and to its journal's page in our library, where you can read the abstract.

2020s

• Editorial Note: Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma. PLOS One Editors. PloS One 2026;21(7):e0353725. Comment · Editorial PubMed · Publisher · Free full text
• Editorial Note: In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma. PLOS One Editors. PloS One 2026;21(7):e0353915. Comment · Editorial PubMed · Publisher · Free full text
• First Central Asian Forum on Lung Cancer. J. Amankulov, D.F. Yankelevitz, A. Mukhamejan, et al. JTO Clinical and Research Reports 2026;7(1):100898. Editorial PubMed · Publisher · Free full text
• Malignant Pleural Mesothelioma: A 2025 Update. G. Cardillo, D. Waller, S. Tenconi, et al. Journal of Clinical Medicine 2025;14(3). Editorial PubMed · Publisher · Free full text
• A multidisciplinary review of several aspects of Asbestos-Related Lung Cancer (ARLC). N. van Zandwijk, A.L. Frank. Lung Cancer 2024;189:107474. Editorial PubMed · Publisher
• Changing trends in mesothelioma: Important lessons for an occupational disease registry. H. Barnes, R.F. Hoy. Respirology 2024;29(4):269-270. Editorial PubMed · Publisher
• Editorial: Asbestos and disease genomics: is mesothelioma a genomic paradigm?. M.C. Jaurand, F. Murphy, E. Felley-Bosco. Frontiers in Toxicology 2024;6:1536344. Editorial PubMed · Publisher · Free full text
• EPA ruling to ban chrysotile asbestos. T. Burki. The Lancet. Oncology 2024;25(5):537. News PubMed · Publisher
• Johnson & Johnson pays $700m to 42 US states to settle Baby Powder asbestos claims. O. Dyer. BMJ 2024;385:q1425. News PubMed · Publisher
• Malignant pleural mesothelioma: The disdained member of thoracic oncology!. D. Khosla, P.K. Singh, B.A. Chhabria, et al. World Journal of Experimental Medicine 2024;14(3):91739. Editorial PubMed · Publisher · Free full text
• Mesothelioma diagnosis-still a challenge. U.P. Santos. Jornal Brasileiro de Pneumologia 2024;50(2):e20240118. Editorial PubMed · Publisher · Free full text
• A WT1-positive pleural neoplasm. Is it always a mesothelioma?: Diagnostic pitfall of WT1 immunohistochemistry in pleural neoplasm. G. Gaggero, D. Taietti, M. Concardi, et al. African Journal of Thoracic and Critical Care Medicine 2023;29(3):1-2. Editorial PubMed · Free full text
• Addressing environmental pollution and cancer: the imperative of the 2030 agenda. R. Bonfiglio, M. Scimeca, A. Mauriello. Future Oncology 2023;19(34):2273-2276. Editorial PubMed · Publisher
• Did the Ban on Asbestos Reduce the Incidence of Mesothelioma?. M. Carbone, H. Yang, H.I. Pass, et al. Journal of Thoracic Oncology 2023;18(6):694-697. Editorial · Comment PubMed · Publisher
• Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?. A. Nakamura, K. Kuribayashi. Translational Lung Cancer Research 2023;12(2):193-196. Editorial · Comment PubMed · Publisher · Free full text
• Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms. M.G. Mastromarino, V. Aprile, M. Lucchi. Frontiers in Oncology 2023;13:1158416. Editorial PubMed · Publisher · Free full text
• Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy. C. Porta, D. Jean, C. Blanquart. Frontiers in Immunology 2023;14:1251384. Editorial PubMed · Publisher · Free full text
• Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets. I. Cavallari, F. Cerciello, E. Giovannetti, et al. Frontiers in Oncology 2023;13:1163144. Editorial PubMed · Publisher · Free full text
• Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease. M. Joshi, B. Varkey. Current Opinion in Pulmonary Medicine 2023;29(2):61-62. Editorial PubMed · Publisher
• FKBP5, a Modulator of Stress Responses Involved in Malignant Mesothelioma: The Link between Stress and Cancer. G. Cugliari. International Journal of Molecular Sciences 2023;24(9). Editorial PubMed · Publisher · Free full text
• Lung cancer: Removing toxic dust from our environment. N. van Zandwijk, H.M. Marshall, K.M. Fong. Respirology 2023;28(6):511-512. Editorial · Comment PubMed · Publisher
• Peritoneal Metastases: Evolution from a Dark Horizon to an Encouraging Present and a Promising Future. M. Diez-Alonso, A. San-Juan, M.A. Ortega, et al. Journal of Clinical Medicine 2023;12(24). Editorial PubMed · Publisher · Free full text
• Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma. M. Lapidot, R. Bueno. Translational Lung Cancer Research 2023;12(2):190-192. Editorial · Comment PubMed · Publisher · Free full text
• Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma. K. Branch, P.S. Adusumilli, M.G. Zauderer. Translational Lung Cancer Research 2023;12(2):187-189. Editorial · Comment PubMed · Publisher · Free full text
• Spare the lung: surgical treatment approach for malignant pleural mesothelioma. N. Fujimoto. Translational Lung Cancer Research 2023;12(2):197-199. Editorial · Comment PubMed · Publisher · Free full text
• Surgical series in mesothelioma: navigating between biases. J. Raskin, P.E. Van Schil, J.P.V. Meerbeeck. Translational Lung Cancer Research 2023;12(2):184-186. Editorial · Comment PubMed · Publisher · Free full text
• A (Controlled) Spill of IL2 for Localized Treatment of Mesothelioma. R. Palanki, K.L. Swingle, M.J. Mitchell. Clinical Cancer Research 2022;28(23):5010-5012. Editorial · Comment PubMed · Publisher · Free full text
• Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma Tumors. A.M. Nash, S. Aghlara-Fotovat, B. Castillio, et al. Clinical Cancer Research 2022;28(23):5121-5135. Editorial PubMed · Publisher · Free full text
• Commentary: A return trip to MARS: Less may be more when treating mesothelioma. C.M. Griffin, V.H. van Berkel. The Journal of Thoracic and Cardiovascular Surgery 2022;163(6):1948-1949. Editorial · Comment PubMed · Publisher
• Commentary: Surgical standardization in mesothelioma trials. V.W. Rusch. The Journal of Thoracic and Cardiovascular Surgery 2022;163(6):1949-1950. Editorial · Comment PubMed · Publisher
• Does the Amount of Asbestos Exposure Influence Prognosis?. H. Yang, G. Gaudino, F. Bardelli, et al. Journal of Thoracic Oncology 2022;17(8):949-952. Editorial · Comment PubMed · Publisher
• Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models. S.K. Lam, S.E. Mutsaers. Frontiers in Pharmacology 2022;13:1015959. Editorial PubMed · Publisher · Free full text
• Malignant mesothelioma: health care awareness and preparedness. E.M. Capitani, E. Algranti. Jornal Brasileiro de Pneumologia 2022;48(5):e20220349. In English, Portuguese. Editorial · Comment PubMed · Publisher · Free full text
• Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?. G.M. Stella, C. Bortolotto. Cancers 2022;14(22). Editorial PubMed · Publisher · Free full text
• Mesothelioma among vehicle mechanics: a controversy?. P.A. Hessel. Thorax 2022;77(5):426-427. Editorial · Comment PubMed · Publisher
• Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic. L. Käsmann, J. Taugner, A. Nieto, et al. Journal of Clinical Medicine 2022;11(19). Editorial PubMed · Publisher · Free full text
• Talc powder and ovarian cancer: what is the evidence?. J.P. Micha, M.A. Rettenmaier, R. Bohart, et al. Archives of Gynecology and Obstetrics 2022;306(4):931-933. News PubMed · Publisher
• The Role of Real-World Evidence to Support Treatment Choices in Malignant Pleural Mesothelioma. P. Wheatley-Price, S. Moore, C.W. Lee. JTO Clinical and Research Reports 2022;3(4):100300. Editorial · Comment PubMed · Publisher · Free full text
• Commentary: Acute kidney injury after intrapleural cisplatin: Minimizing collateral damage. M.I. Ebright. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1522-1523. Editorial · Comment PubMed · Publisher
• Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma. S.S. Groth, R.T. Ripley. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1519-1520. Editorial · Comment PubMed · Publisher
• Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma. A. Bribriesco. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1520-1522. Editorial · Comment PubMed · Publisher
• Divided by an ocean of water but united in an ocean of uncertainty: A transatlantic review of mesothelioma surgery guidelines. D.A. Waller, I. Opitz, R. Bueno, et al. The Journal of Thoracic and Cardiovascular Surgery 2021;161(6):1922-1925. Editorial PubMed · Publisher
• Editorial: Epigenetic Modifications in Mesothelioma. Y.Y. Cheng, M.L. Yuen, H. Jin. Frontiers in Oncology 2021;11:650136. Editorial PubMed · Publisher · Free full text
• Epidemiological Research on Occupational and Environmental Carcinogens. C. Ledda. International Journal of Environmental Research and Public Health 2021;18(5). Editorial PubMed · Publisher · Free full text
• Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma. M. Migliore, M. Ried, L. Molins, et al. Annals of Translational Medicine 2021;9(11):960. Editorial PubMed · Publisher · Free full text
• Malignant Mesothelioma. D.L. Pouliquen, J. Kopecka. Cancers 2021;13(14). Editorial PubMed · Publisher · Free full text
• Malignant Pleural Mesothelioma-Does Ki67 Make the Grade?. O.W.J. Prall. JTO Clinical and Research Reports 2021;2(5):100170. Editorial PubMed · Publisher · Free full text
• Malignant Pleural Mesothelioma: Time Is Running Out. F. Lococo. Journal of Clinical Medicine 2021;10(4). Editorial PubMed · Publisher · Free full text
• Mesothelioma. M. Deraco. Cancers 2021;13(13). Editorial PubMed · Publisher · Free full text
• Personalized Prognostication in Malignant Pleural Effusion: The Next Step?. D.N. Addala, N.M. Rahman, F. Maldonado. Chest 2021;160(3):805-806. Editorial · Comment PubMed · Publisher
• Asbestos, Pleural Plaques, and Lung Cancer: Untangling the Relationships. P. Harber. American Journal of Respiratory and Critical Care Medicine 2020;201(1):4-6. Editorial · Comment PubMed · Publisher · Free full text
• Baby Powders and the Precautionary Principle. D. Rosner, G. Markowitz. American Journal of Public Health 2020;110(9):1378-1379. Editorial PubMed · Publisher · Free full text
• Categorical systems for reporting of cytology specimens: Following the footsteps of Bethesda-like reporting systems. L.J. Layfield, Z. Baloch. Diagnostic Cytopathology 2020;48(10):859-861. Editorial PubMed · Publisher
• Comment on "EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach". W.T. Vigneswaran, M. Kittaneh. Translational Lung Cancer Research 2020;9(6):2508-2510. Editorial · Comment PubMed · Publisher · Free full text
• Commentary: A journey of a thousand miles begins with a single step. T.F. Chen-Yoshikawa. The Journal of Thoracic and Cardiovascular Surgery 2020;159(5):2092-2093. Editorial · Comment PubMed · Publisher
• Commentary: Biphasic malignant mesothelioma-Survival of the fittest. L.M. Felmly, B.C. Gibney. The Journal of Thoracic and Cardiovascular Surgery 2020;159(4):1596-1597. Editorial · Comment PubMed · Publisher
• Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?. R.T. Ripley. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1086-1087. Editorial · Comment PubMed · Publisher
• Commentary: Focused attention on proactive identification of deep venous thrombosis after pleurectomy/decortication for malignant pleural mesothelioma. S.S. Groth, R.T. Ripley, P.W. Carrott, et al. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1075-1076. Editorial · Comment PubMed · Publisher
• Commentary: Go small or go home. A.W. Kim, U. Ahmad. The Journal of Thoracic and Cardiovascular Surgery 2020;160(3):e173-e174. Editorial · Comment PubMed · Publisher
• Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?. M. de Perrot. The Journal of Thoracic and Cardiovascular Surgery 2020;159(6):2520-2521. Editorial · Comment PubMed · Publisher
• Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma. A.E. Giles, B. Kidane. The Journal of Thoracic and Cardiovascular Surgery 2020;159(6):2523-2524. Editorial · Comment PubMed · Publisher
• Commentary: Local chemotherapy with nanoparticles: A ray of light in the dark?. S. Nakamura, T.F. Chen-Yoshikawa. The Journal of Thoracic and Cardiovascular Surgery 2020;160(3):e169-e170. Editorial · Comment PubMed · Publisher
• Commentary: Mesothelioma … moving the needle on locoregional control has invited aggressive treatment options for limited distant metastases. M. Lanuti. JTCVS Techniques 2020;3:363-364. Editorial PubMed · Publisher · Free full text
• Commentary: Mesothelioma: The Guinness world record holder in thromboembolism. R.B. Cameron. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1074-1075. Editorial · Comment PubMed · Publisher
• Commentary: Not only SMART clinically, but translationally!. H.I. Pass. The Journal of Thoracic and Cardiovascular Surgery 2020;159(5):2094-2095. Editorial · Comment PubMed · Publisher
• Commentary: One nano-step for murinekind, one giant leap for mesothelioma. J.S. Dutcher, J. D'Cunha. The Journal of Thoracic and Cardiovascular Surgery 2020;160(3):e170-e171. Editorial · Comment PubMed · Publisher
• Commentary: Picking the winners-Leaning into selection bias. E. Wakeam, B. Kidane. The Journal of Thoracic and Cardiovascular Surgery 2020;159(4):1594-1595. Editorial · Comment PubMed · Publisher
• Commentary: Surgeon versus mesothelioma in a thoracic cage match. C.D. Hoang. The Journal of Thoracic and Cardiovascular Surgery 2020;159(6):2522-2523. Editorial · Comment PubMed · Publisher
• Commentary: Tasting individual ingredients of meso soup: Can 'omics bring out the flavor?. H.I. Pass. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1084-1085. Editorial · Comment PubMed · Publisher
• Commentary: To scan or not to scan: No longer the question for mesothelioma patients after pleurectomy. E.A. David, S.M. Atay. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1076-1077. Editorial · Comment PubMed · Publisher
• Commentary: When cancer is oligometastatic, even mesothelioma is curable. A.E. Abbas. JTCVS Techniques 2020;3:361-362. Editorial PubMed · Publisher · Free full text
• Editorial: Emerging Therapies for Malignant Mesothelioma. N. van Zandwijk, G. Reid, P. Baas. Frontiers in Oncology 2020;10:939. Editorial PubMed · Publisher · Free full text
• IASLC 2020 World Conference on Lung Cancer. P. Venkatesan. The Lancet. Respiratory Medicine 2020;8(10):e76. News PubMed · Publisher
• Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas. D.T. Severson, A. De Rienzo, R. Bueno. The Journal of Thoracic and Cardiovascular Surgery 2020;160(4):1078-1083.e2. Editorial · Comment PubMed · Publisher · Free full text
• Natriuretic peptides in pleural effusions: Beyond a diagnosis of heart failure. J.M. Porcel. Respirology 2020;25(10):1021-1022. Editorial · Comment PubMed · Publisher
• Personalized Oncolytic Therapy: The Next Step Toward the Successful Clinical Application of Vaccine-Strain Measles Viruses for Cancer Therapy?. T. Peikert. Journal of Thoracic Oncology 2020;15(5):689-691. Editorial · Comment PubMed · Publisher
• Prognostication in malignant pleural effusion: One size does not fit all. A. Dipper, N. Maskell. Respirology 2020;25(12):1229-1230. Editorial · Comment PubMed · Publisher
• Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back. P. Astoul. Translational Lung Cancer Research 2020;9(4):1613-1616. Editorial · Comment PubMed · Publisher · Free full text
• This special volume of mesothelioma is dedicated to my friend Adi Gazdar. M. Carbone. Translational Lung Cancer Research 2020;9(Suppl 1):S1-S2. Editorial PubMed · Publisher · Free full text
• Transitional Mesothelioma and Artificial Intelligence: Do We Need One More Subtype? and Do We Need Computers to Identify Them?. M. Carbone. Journal of Thoracic Oncology 2020;15(6):884-887. Editorial · Comment PubMed · Publisher

2010s

• A thinner peel to peel: Pleural thickness is prognostic in mesothelioma. S.S. Groth, R.T. Ripley, B.M. Burt. The Journal of Thoracic and Cardiovascular Surgery 2019;157(1):414-415. Editorial · Comment PubMed · Publisher

• Asbestos exposure: the dust cloud lingers. The Lancet Oncology. The Lancet. Oncology 2019;20(8):1035. Editorial PubMed · Publisher

• Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention. S.S. Groth, B.M. Burt, R.T. Ripley. The Journal of Thoracic and Cardiovascular Surgery 2019;158(3):932-933. Editorial · Comment PubMed · Publisher

• Commentary: Return to intended radiation therapy-Criteria for resection?. J. Dux, R. Grosser, P.S. Adusumilli. The Journal of Thoracic and Cardiovascular Surgery 2019;158(3):930-931. Editorial · Comment PubMed · Publisher · Free full text

• Does Chromothripsis Make Mesothelioma an Immunogenic Cancer?. M. Carbone, H. Yang, G. Gaudino. Journal of Thoracic Oncology 2019;14(2):157-159. Editorial · Comment PubMed · Publisher · Free full text

• Environmental exposures and cancer: using the precautionary principle. L. Cohen, A. Jefferies. Ecancermedicalscience 2019;13:ed91. Editorial PubMed · Publisher · Free full text

• How Old is Too Old to Operate for Mesothelioma?. J.M. Karush. Annals of Surgical Oncology 2019;26(8):2311-2312. Editorial PubMed · Publisher

• Mesothelioma: Hippo pathway as a target, lessons from COMMAND. D.A. Fennell, E.Y. Baitei. Oncotarget 2019;10(40):3996-3997. Editorial PubMed · Publisher · Free full text

• Nonexpandable Lung: More Than Just a Call from Radiology. D. Feller-Kopman. Annals of the American Thoracic Society 2019;16(10):1240-1242. Editorial · Comment PubMed · Publisher

• Palliative care in mesothelioma: Are current services RESPECT-able enough?. N. Kumar, D. Alrifai, I. Psallidas. Thorax 2019;74(4):326-327. Editorial · Comment PubMed · Publisher

• Pleural mesothelioma: tackling a deadly cancer. The Lancet Respiratory Medicine. The Lancet. Respiratory Medicine 2019;7(2):99. Editorial PubMed · Publisher

• Shining Light on Pleural Biopsy in Mesothelioma: Is It Time to Get "Smart"?. E.O. Bedawi, N.M. Rahman. Chest 2019;156(4):643-644. Editorial · Comment PubMed · Publisher

• To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma. B.M. Burt, R.T. Ripley, S.S. Groth. The Journal of Thoracic and Cardiovascular Surgery 2019;157(2):767-768. Editorial · Comment PubMed · Publisher

• Biomarkers in malignant pleural mesothelioma: current status and future directions. T. Ahmadzada, G. Reid, S. Kao. Journal of Thoracic Disease 2018;10(Suppl 9):S1003-S1007. Editorial · Comment PubMed · Publisher · Free full text

• Current surgical treatment of malignant pleural mesothelioma. K. Chihara. Respiratory Investigation 2018;56(4):265-266. Editorial PubMed · Publisher

• Immunotherapy in relapsed mesothelioma. S. Brosseau, X. Dhalluin, G. Zalcman, et al. Immunotherapy 2018;10(2):77-80. Editorial PubMed · Publisher

• Malignant mesothelioma clinical trial combines immunotherapy drugs. M.S. Chatwal, T. Tanvetyanon. Immunotherapy 2018;10(5):341-344. Editorial PubMed · Publisher

• Mesothelioma: Live to fight another day. A.S. Wolf, R.M. Flores. The Journal of Thoracic and Cardiovascular Surgery 2018;155(4):1855-1856. Editorial PubMed · Publisher

• Prof. Nico van Zandwijk: all forms of asbestos are carcinogenic and safe use of asbestos is an illusion. V. Kong. Annals of Translational Medicine 2018;6(15):310. News PubMed · Publisher · Free full text

• Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma. D.A. Fennell. Journal of Thoracic Oncology 2018;13(10):1436-1437. Editorial · Comment PubMed · Publisher

• Revised Modified RECIST Criteria in Malignant Pleural Mesothelioma (Version 1.1): A Step Forward in a Long Race. A.S. Tsao, G.W. Gladish, R.R. Gill. Journal of Thoracic Oncology 2018;13(7):871-873. Editorial · Comment PubMed · Publisher

• Special Issue on Mechanisms of Mesothelioma Heterogeneity: Highlights and Open Questions. E. Felley-Bosco. International Journal of Molecular Sciences 2018;19(11). Editorial PubMed · Publisher · Free full text

• Surgery for mesothelioma: Less is more, more or less. S. Milman, T. Ng. The Journal of Thoracic and Cardiovascular Surgery 2018;155(4):1867-1868. Editorial · Comment PubMed · Publisher

• The C-Reactive Protein/Albumin Ratio May Predict the Long-Term Outcome in Patients with Malignant Pleural Mesothelioma. N. Yoshida, H. Baba. Annals of Surgical Oncology 2018;25(6):1471-1472. Editorial · Comment PubMed · Publisher

• Therapeutic R2 resection for pleural mesothelioma. D. Nguyen, D.J. Sugarbaker, B.M. Burt. The Journal of Thoracic and Cardiovascular Surgery 2018;155(6):2734-2735. Editorial · Comment PubMed · Publisher

• Treat it or Leave it: Immuno-Oncology in Mesothelioma Observed by the Eyes of Argus. C.J. de Gooijer, P. Baas. Journal of Thoracic Oncology 2018;13(11):1619-1622. Editorial · Comment PubMed · Publisher

• Data on mesothelioma mortality: a powerful tool for preventing asbestos-related disease. P.J. Landrigan. Occupational and Environmental Medicine 2017;74(12):849-850. Editorial PubMed · Publisher

• Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma. G. Pinton, L. Moro. Future Science OA 2017;3(2):FSO175. Editorial PubMed · Publisher · Free full text

• Genes versus Environment: cytoplasmic BAP1 determines the toxic response to environmental stressors in mesothelioma. I. Amelio. Cell Death & Disease 2017;8(6):e2907. News PubMed · Publisher · Free full text

• Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?. A.S. Mansfield. Lung Cancer 2017;105:49-51. Editorial PubMed · Publisher

• Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment. C.J. Ban, H.Z. Shi, Y.H. Zhang. Chinese Medical Journal 2017;130(1):1-3. Editorial PubMed · Publisher · Free full text

• Is immunotherapy a viable option in treating mesothelioma?. D.W. Dumoulin, J.G. Aerts, R. Cornelissen. Future Oncology 2017;13(20):1747-1750. Editorial PubMed · Publisher

• Is Mesothelioma in China Rare or Misdiagnosed?. T. John, P.A. Russell, B. Thapa. Journal of Thoracic Oncology 2017;12(4):607-609. Editorial · Comment PubMed · Publisher

• Low-level toxicity of chemicals: No acceptable levels?. B.P. Lanphear. PLoS Biology 2017;15(12):e2003066. Editorial PubMed · Publisher · Free full text

• PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better?. S. Lantuejoul, N. Le Stang, F. Damiola, et al. Journal of Thoracic Oncology 2017;12(5):778-781. Editorial · Comment PubMed · Publisher

• Pleural IMRT after Lung-Sparing Cytoreduction for Mesothelioma: Mature Enough to Randomize. H.I. Pass. Journal of Thoracic Oncology 2017;12(6):919-921. Editorial · Comment PubMed · Publisher

• Quantifying asbestos in lung tissue: what debate?. B. Nemery, V. Nuyts, K. Nackaerts. The European Respiratory Journal 2017;49(6). Editorial · Comment PubMed · Publisher

• Targeting BAP1: a new paradigm for mesothelioma. L.M. Schunselaar, W. Zwart, P. Baas. Lung Cancer 2017;109:145-146. Editorial PubMed · Publisher

• A regional approach for CAR T-cell therapy for mesothelioma: from mouse models to clinical trial. M. Mayor, M. Zeltsman, E. McGee, et al. Immunotherapy 2016;8(5):491-4. Editorial PubMed · Publisher

• Arginine deprivation for ASS1-deficient mesothelioma. T.K. Burki. The Lancet. Oncology 2016;17(10):e423. News PubMed · Publisher

• Asbestos and product defence science. B. Terracini, D. Mirabelli. International Journal of Epidemiology 2016;45(3):614-8. Editorial PubMed · Publisher

• Asbestos concerns in Australian buildings. T.K. Burki. The Lancet. Oncology 2016;17(9):e377. News PubMed · Publisher

• Construction and demolition waste management: China's lessons. H. Duan, J. Li. Waste Management & Research 2016;34(5):397-8. Editorial PubMed · Publisher

  In plain English

  This was a two-page editorial, not a research study. It reported no new data and did not measure asbestos exposure or disease. The authors wrote about construction and demolition (C&D) waste in China. Citing a China Daily report, they opened with the 20 December 2015 landslide of piled waste in Shenzhen, which buried nearly three dozen buildings and left at least 75 people missing. Citing a government report, they wrote that China produced roughly 1 billion tonnes of C&D waste in 2013 and that about 5% was reused or recycled. On asbestos, the authors stated that many old buildings in China nearing the end of their life contain asbestos. They wrote that, unlike many developed countries, China still used asbestos in rural or less-developed regions and lacked a sound system for managing C&D waste containing asbestos. They also described heavy metals and brominated flame retardants as probable contaminants of this waste, noting that little research had characterised the flame retardants in C&D waste. The authors concluded that a system is needed to separate hazardous materials, including asbestos, from C&D waste.

  We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

• Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges. G.L. Ceresoli, M. Bonomi, M.G. Sauta. Expert Review of Anticancer Therapy 2016;16(7):673-5. Editorial PubMed · Publisher

• Low Wages as Occupational Health Hazards. J.P. Leigh, R. De Vogli. Journal of Occupational and Environmental Medicine 2016;58(5):444-7. Editorial PubMed · Publisher

• Malignant pleural mesothelioma. W. Klepetko. Wiener Klinische Wochenschrift 2016;128(17-18):609-10. Editorial PubMed · Publisher

• Modulating Immunosuppression in the Intrapleural Space of Malignant Pleural Mesothelioma and Predictive Biomarkers to Guide Treatment Decisions. R.M. Wong. Journal of Thoracic Oncology 2016;11(10):1602-3. Editorial PubMed · Publisher

• Pleurectomy decortication for mesothelioma: The procedure of choice when possible. R.M. Flores. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):310-2. Editorial PubMed · Publisher

• Preface: Respirable elongated mineral particles and human health-Revisited. R.F. Dodson. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 2016;19(5-6):149-150. Editorial PubMed · Publisher

• SMART or simply bold?. V.W. Rusch, A. Rimner, P.S. Adusumilli. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):476-7. Editorial · Comment PubMed · Publisher

• The mesothelioma surgery shift. R.M. Flores. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):485-6. Editorial · Comment PubMed · Publisher

• The staging of malignant pleural mesothelioma: are we any nearer to squaring the circle?. D.A. Waller. European Journal of Cardio-thoracic Surgery 2016;49(6):1648-9. Editorial · Comment PubMed · Publisher

• What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice. T. Treasure. The Journal of Thoracic and Cardiovascular Surgery 2016;151(2):307-9. Editorial PubMed · Publisher

• 2015 American Society of Clinical Oncology annual meeting. S. Cleghorn. The Lancet. Respiratory Medicine 2015;3(7):516-7. News PubMed · Publisher

• 50th Anniversary Perspective on Volume 1: Urschel HC, Paulson DL. Mesotheliomas of the Pleura. Ann Thorac Surg 1965;1:559-73. V.W. Rusch. The Annals of Thoracic Surgery 2015;100(4):1148-50. Editorial · Historical article PubMed · Publisher

• An update on pleuro-pulmonary cytopathology: Part i: Cytological diagnosis of mesothelioma and molecular cytology of lung cancer with an historical perspective. C.W. Bedrossian. Diagnostic Cytopathology 2015;43(7):513-26. Editorial · Historical article · Review PubMed · Publisher

• ASIA: asbestos stop in Asia. P. Baas, S. Burgers. Respirology 2015;20(4):521. Editorial · Comment PubMed · Publisher

• Eliminating occupational cancer. J. Takala. Industrial Health 2015;53(4):307-9. Editorial PubMed · Publisher · Free full text

• Elimination of Asbestos-Related Diseases in Turkey Still Has a Long Way to Go. M. Akgün. Turkish Thoracic Journal 2015;16(3):105-106. Editorial PubMed · Publisher · Free full text

• Epidemics of asbestos-related diseases--something old, something new. H. Vainio. Scandinavian Journal of Work, Environment & Health 2015;41(1):1-4. Editorial · Comment PubMed · Publisher

• Erionite and cancer in a Mexican village. R. Saracci. Occupational and Environmental Medicine 2015;72(3):163-4. Editorial · Comment PubMed · Publisher

• Fifteen years in the evaluation of extrapleural pneumonectomy: Lessons to be learned. T. Treasure, F. Macbeth. The Journal of Thoracic and Cardiovascular Surgery 2015;149(5):1382-3. Editorial · Comment PubMed · Publisher

• Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Applicable to all and by all?. R. Haas, P. Baas. Journal of Medical Imaging and Radiation Oncology 2015;59(3):353-4. Editorial · Comment PubMed · Publisher

• Into another dimension: Assessing novel therapeutics in a more lifelike microenvironment. M.B. Antonoff. The Journal of Thoracic and Cardiovascular Surgery 2015;149(5):1426-7. Editorial · Comment PubMed · Publisher

• Povidone iodine: the new solution for mesothelioma?. V.W. Rusch. The Journal of Thoracic and Cardiovascular Surgery 2015;149(2):567-8. Editorial · Comment PubMed · Publisher

• Recent insights emerging from malignant mesothelioma genome sequencing. M. Carbone, G. Gaudino, H. Yang. Journal of Thoracic Oncology 2015;10(3):409-11. Editorial · Comment PubMed · Publisher · Free full text

• Retroperitoneal fibrosis and asbestosis--a plausible association?. R.D. Swartz. American Journal of Kidney Diseases 2015;65(3):378-80. Editorial · Comment PubMed · Publisher

• The evolving role of effusion cytology in the diagnosis of malignant mesothelioma. A. Paintal. Cytopathology 2015;26(3):137-8. Editorial · Comment PubMed · Publisher

• The mesothelioma enigma. R.M. Flores. The Journal of Thoracic and Cardiovascular Surgery 2015;149(6):1548-9. Editorial · Comment PubMed · Publisher

• The Second Mediterranean Symposium: considering mesothelioma from a local and international perspective. T. Treasure. Future Oncology 2015;11(24 Suppl):5-6. Editorial PubMed · Publisher

• Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2. A.A. Chokoeva, G. Tchernev, J.C. Cardoso, et al. International Journal of Immunopathology and Pharmacology 2015;28(2):178-86. Editorial · Review PubMed · Publisher

• Asbestos: a continuing failure of ethics by McGill University. K. Ruff. International Journal of Occupational and Environmental Health 2014;20(1):1-3. Editorial PubMed · Publisher · Free full text

• Canberra Government to demolish asbestos-contaminated homes. T. Kirby. The Lancet. Respiratory Medicine 2014;2(12):975. News PubMed · Publisher

• Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Y. Grosse, D. Loomis, K.Z. Guyton, et al. The Lancet. Oncology 2014;15(13):1427-1428. News PubMed · Publisher

• Immunological effects of environmental factors: focus on the fibrous and particulated materials. T. Otsuki, A. Holian, M. Di Gioacchino. Journal of Immunology Research 2014;2014:697438. Editorial PubMed · Publisher · Free full text

• International scientific cooperation on asbestos-related disease prevention in Latin America. D. Marsili, P. Comba, R. Pasetto, et al. Annals of Global Health 2014;80(4):247-50. Editorial PubMed · Publisher

• Mesothelial proliferations: useful marker is not the same as a diagnostic one. A.N. Husain. American Journal of Clinical Pathology 2014;141(2):152-3. Editorial · Comment PubMed · Publisher

• Multimodal management of malignant pleural mesothelioma: where are we today?. P.E. Van Schil, I. Opitz, W. Weder, et al. The European Respiratory Journal 2014;44(3):754-64. Editorial PubMed · Publisher

• Regional delivery of oncolytic vaccinia virus: it's time for clinical trials. S. Downs-Canner, D.L. Bartlett. Annals of Surgical Oncology 2014;21(7):2127-8. Editorial · Comment PubMed · Publisher · Free full text

• Staphylococcus aureus bio-products: new biological roles for a pleurodesis agent. I. Psallidas, G.T. Stathopoulos. Respirology 2014;19(7):948-9. Editorial · Comment PubMed · Publisher

• Surgery for malignant pleural mesothelioma: why we need controlled trials. T. Treasure, M. Dusmet, F. Fiorentino, et al. European Journal of Cardio-thoracic Surgery 2014;45(4):591-2. Editorial PubMed · Publisher

• The challenge of malignant pleural mesothelioma: new directions. V.W. Rusch, A. Rimner, L.M. Krug. Journal of Thoracic Oncology 2014;9(3):271-2. Editorial · Comment PubMed · Publisher

• Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma. P.S. Adusumilli. Cancer 2014;120(21):3268-71. Editorial · Comment PubMed · Publisher · Free full text

• A worldwide ban on asbestos production and use: some recent progress, but more still to be done. M.R. Sim. Occupational and Environmental Medicine 2013;70(1):1-2. Editorial PubMed · Publisher

• Accurate diagnosis of mesothelioma: more important than ever. T.C. Allen. Archives of Pathology & Laboratory Medicine 2013;137(5):601-2. Editorial · Comment PubMed · Publisher

• Asbestos and lung cancer: what we know. J.R. Balmes. American Journal of Respiratory and Critical Care Medicine 2013;188(1):8-9. Editorial · Comment PubMed · Publisher

• Biomarker agreement entered into by Verastem and Laboratory Corporation of America® Holdings. C. Attwood. Bioanalysis 2013;5(5):525. News PubMed · Publisher

• Commentary on 'evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature', Donovan et al.1. D.S. Egilman, N.M. Druar. International Journal of Occupational and Environmental Health 2013;19(3):163-8. Editorial · Comment PubMed · Publisher

• Detection of mesothioloma remains a conundrum. R. Kratzke. Journal of the National Cancer Institute 2013;105(4):254-5. Editorial · Comment PubMed · Publisher

• IARC in the dock over ties with asbestos industry. D. Holmes. Lancet 2013;381(9864):359-61. News PubMed · Publisher

• Ken Donaldson: retirement of a young mind. P. Borm, F.R. Cassee. Particle and Fibre Toxicology 2013;10:8. Editorial · Historical article PubMed · Publisher · Free full text

• Nanomedicine: experts state safety concerns regarding carbon nanotubes have been allayed by chemistry. P. Nagda. Nanomedicine 2013;8(3):325-6. News PubMed · Publisher

• Researchers explore possible link between mesothelioma and dust emissions in southern Nevada. L.H. O'Hanlon. Journal of the National Cancer Institute 2013;105(5):312-4. News PubMed · Publisher

• The importance of scientific debate. D.S. Egilman. International Journal of Occupational and Environmental Health 2013;19(3):157-9. Editorial · Comment PubMed · Publisher

• The JPC-SE position statement on asbestos: a long-overdue appeal by epidemiologists to ban asbestos worldwide and end related global environmental injustice. W.K. Al-Delaimy. Environmental Health Perspectives 2013;121(5):a144-5. Editorial PubMed · Publisher · Free full text

• UN Scientific Agency collaborating with scientists involved in sabotaging UN Rotterdam Convention. K. Ruff. International Journal of Occupational and Environmental Health 2013;19(3):160-2. Editorial PubMed · Publisher

• War on Carcinogens: industry disputes human relevance of chemicals causing cancer in laboratory animals based on unproven hypotheses, using kidney tumors as an example. R.L. Melnick, J.M. Ward, J. Huff. International Journal of Occupational and Environmental Health 2013;19(4):255-60. Editorial PubMed · Publisher

• Why pretend that "non-asbestos" fibrous silicates are not "asbestos"?. T.L. Guidotti. Archives of Environmental & Occupational Health 2013;68(4):187-9. Editorial PubMed · Publisher

• A call to action: epidemiologists assert themselves with scientific data. S.H. Weiss. International Journal of Occupational and Environmental Health 2012;18(3):167-70. Editorial PubMed · Publisher

• Asbestos in Canada: the end is in sight. T.L. Guidotti. Archives of Environmental & Occupational Health 2012;67(1):1-2. Editorial · Historical article PubMed · Publisher

• Asbestos kills: no matter how you cut the data. D.R. Smith, E.J. Beh. Archives of Environmental & Occupational Health 2012;67(4):187-8. Editorial PubMed · Publisher

• Asbestos: avoiding a pyrrhic victory. G. Paradis. Canadian Journal of Public Health = Revue Canadienne de Santé Publique 2012;103(5):e321. Editorial PubMed · Publisher · Free full text

• Brazil on the road to the elimination of asbestos. H.A. Castro. Cadernos de Saúde Pública 2012;28(5):816-7. In English, Portuguese. Editorial PubMed · Publisher

• China and the US: asbestos in common. A.L. Frank. International Journal of Occupational and Environmental Health 2012;18(3):179-80. Editorial · Comment PubMed · Publisher

• Is it time to consider pleurectomy and decortication as the only surgical treatment for malignant pleural mesothelioma?. M.J. Weyant. Journal of Thoracic Oncology 2012;7(4):629-30. Editorial PubMed · Publisher

• Modulating mesothelin shedding to improve therapy. I. Pastan, Y. Zhang. Oncotarget 2012;3(2):114-5. Editorial PubMed · Publisher · Free full text

• Primum non nocere? Does this also apply to mesothelioma?. P. Baas. Lung Cancer 2012;77(1):1. Editorial PubMed · Publisher

• Quebec and Canadian governments end their historic support of the asbestos industry. K. Ruff. International Journal of Occupational and Environmental Health 2012;18(4):263-7. Editorial PubMed · Publisher

• Robust data: the essential foundation of a revised staging system for pleural mesothelioma. H.L. Kindler. Journal of Thoracic Oncology 2012;7(11):1623-4. Editorial PubMed · Publisher

• Shattered lives: asbestos-related diseases. S. Sharma. Current Opinion in Pulmonary Medicine 2012;18(4):375-6. Editorial PubMed · Publisher

• The asbestos disease epidemic: here today, here tomorrow. P. Cullinan, N. Pearce. Thorax 2012;67(2):98-9. Editorial · Comment PubMed · Publisher

• The traveling Libby legacy: Minnesota community exhibits nonoccupational health impacts consistent with asbestos damage. T. Tillett. Environmental Health Perspectives 2012;120(1):A35. News · Comment PubMed · Publisher · Free full text

• A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS). T. Treasure, E. Internullo, F. Fiorentino, et al. Interactive Cardiovascular and Thoracic Surgery 2011;12(3):341-6. Editorial PubMed · Publisher

• Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?. A.J. Rai, R.M. Flores. Clinical Chemistry and Laboratory Medicine 2011;49(1):5-7. Comment · Editorial PubMed · Publisher

• Facts, rumours and speculations about the mesothelioma epidemic. J.P. van Meerbeeck, R. Damhuis. Respirology 2011;16(7):1018-9. Editorial · Comment PubMed · Publisher

• Germline BAP1 mutations and tumor susceptibility. A.M. Goldstein. Nature Genetics 2011;43(10):925-6. News · Comment PubMed · Publisher · Free full text

• Lack of evidence in malignant pleural mesothelioma surgery. O. Rena, C. Casadio. Interactive Cardiovascular and Thoracic Surgery 2011;12(3):347-8. Comment · Editorial PubMed · Publisher

• Medicolegal aspects of the third wave of asbestos-related disease in Australia. J.R. Gordon, J. Leigh. The Medical Journal of Australia 2011;195(5):247-8. Editorial · Comment PubMed · Publisher

• Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?. G. Zalcman, E. Bergot, E. Lechapt. Lung Cancer 2011;72(1):1-2. Editorial PubMed · Publisher

• Renovation and renewal. A. Katelaris. The Medical Journal of Australia 2011;195(5):245. Editorial · Comment PubMed · Publisher

• Respiratory illness in asbestos contaminated sites: the role of environmental exposure. P. Comba, L. Fazzo, A. Zona. The European Respiratory Journal 2011;38(2):248-50. Comment · Editorial PubMed · Publisher

• Should cytology be an acceptable means of diagnosing malignant mesothelioma?. M. Sheaff. Cytopathology 2011;22(1):3-4. Comment · Editorial PubMed · Publisher

• Stop Canadian death export of asbestos. P. Leuprecht. International Journal of Occupational and Environmental Health 2011;17(3):285-6. Editorial PubMed · Publisher

• Surgery and mesothelioma: if not randomization, at least standardization and registration!. H. Pass. Lung Cancer 2011;71(1):1-2. Editorial PubMed · Publisher

• The need for randomized trials in mesothelioma: let's walk the talk. T. Treasure, S. Senan. The Oncologist 2011;16(3):261-3. Comment · Editorial PubMed · Publisher · Free full text

• Where there is asbestos, there is mesothelioma: filling in the data blanks. R.C. Haynes. Environmental Health Perspectives 2011;119(4):A177. Comment · News PubMed · Publisher · Free full text

• A repeat call for the banning of asbestos. L.S. Birnbaum, J.C. Schroeder, H.A. Tilson. Environmental Health Perspectives 2010;118(7):A280-1. Comment · Editorial PubMed · Publisher · Free full text

• A worn-out welcome: renewed call for a global ban on asbestos. R.C. Haynes. Environmental Health Perspectives 2010;118(7):A298-303. Comment · News PubMed · Publisher · Free full text

• Asbestos and lung disease. A.R. Brody. American Journal of Respiratory Cell and Molecular Biology 2010;42(2):131-2. Comment · Editorial · Review PubMed · Publisher

• Asbestos is still with us: repeat call for a universal ban. Collegium Ramazzini. Occupational Medicine 2010;60(8):584-5. Editorial PubMed · Publisher

• Asbestos is still with us: repeat call for a universal ban. C. Ramazzini. Journal of Occupational and Environmental Medicine 2010;52(5):469-72. Editorial PubMed · Publisher

• Asbestos scandal. Nature 2010;468(7326):868. Editorial PubMed · Publisher

• Asbestos still poses a threat to global health: now is the time for action. P.D. Sly, R. Chase, J. Kolbe, et al. The Medical Journal of Australia 2010;193(4):198-9. Editorial PubMed · Publisher

• Ban all production and export of chrysotile asbestos. G. Paradis. Canadian Journal of Public Health = Revue Canadienne de Santé Publique 2010;101(5):352. In English, French. Editorial PubMed · Publisher · Free full text

• Canada accused of hypocrisy over asbestos exports. T. Kirby. Lancet 2010;376(9757):1973-4. News PubMed · Publisher

• Does asbestos exposure (asbestosis) cause (clinical) airway obstruction (small airway disease)?. A. Miller, W.N. Rom. American Journal of Respiratory and Critical Care Medicine 2010;182(4):444-5. Comment · Editorial PubMed · Publisher

• Editorial comment May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?. I. Opitz. European Journal of Cardio-thoracic Surgery 2010;38(3):252-3. Comment · Editorial PubMed · Publisher

• Evidence of carcinogenicity in humans of water-soluble nickel salts. T.K. Grimsrud, A. Andersen. Journal of Occupational Medicine and Toxicology 2010;5:7. Editorial PubMed · Publisher · Free full text

• Exporting death made in Quebec. G. Paradis. Canadian Journal of Public Health = Revue Canadienne de Santé Publique 2010;101(2):112. In English, French. Editorial PubMed · Publisher · Free full text

• Health experts concerned over India's asbestos industry. T. Burki. Lancet 2010;375(9715):626-7. News PubMed · Publisher

• Iodopovidone as a pleurodesis agent: setting standards for clinical pleural research. A.H. Diacon. Respirology 2010;15(1):4-5. Editorial · Comment PubMed · Publisher

• Mesothelioma: an inviting but challenging target for gene therapy. R.G. Crystal. American Journal of Respiratory Cell and Molecular Biology 2010;42(4):383-4. Comment · Editorial PubMed · Publisher

• Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?. K. Tamura, Y. Fujiwara. Asia-Pacific Journal of Clinical Oncology 2010;6(4):248-50. Comment · Editorial PubMed · Publisher

• Quebec stands firm on asbestos exports despite growing controversy. L. Eggertson. CMAJ 2010;182(5):E239-40. News PubMed · Publisher · Free full text

• Scientists protest about Quebec's "hypocrisy" over export of asbestos. D. Spurgeon. BMJ 2010;340:c639. News PubMed · Publisher

• Surgery for mesothelioma: MARS landing and future missions. T. Treasure. European Journal of Cardio-thoracic Surgery 2010;37(3):509-10. Editorial PubMed · Publisher

• Surgical treatment of malignant peritoneal mesothelioma: past, present, and future. H.R. Alexander. Annals of Surgical Oncology 2010;17(1):21-2. Comment · Editorial PubMed · Publisher · Free full text

• Taking a retrospective look at asbestos-related thoracic disease produces interesting results. E.B. Gottschall. Radiology 2010;255(3):681-2. Editorial · Comment PubMed · Publisher

2000s

• Asbestos exposure and laryngeal cancer: is there an association?. S.M. Ahmad, R.T. Sataloff. Ear, Nose, & Throat Journal 2009;88(10):1140-2. Editorial PubMed
• Asbestos panel chair mystified by secrecy surrounding report. R. Collier. CMAJ 2009;180(11):1100-1. News PubMed · Publisher · Free full text
• Asbestos production increases despite WHO opposition. T. Burki. The Lancet. Oncology 2009;10(9):846. News PubMed · Publisher
• Asbestos related disease investigated. British Dental Journal 2009;206(10):512. Comment · News PubMed · Publisher
• Asbestos, lung cancer and mesothelioma in the British Journal of Industrial Medicine. A. Newman Taylor. Occupational and Environmental Medicine 2009;66(7):426-7. Editorial · Historical article PubMed · Publisher
• Canadian chrysotile report released--at last. T.L. Ogden. The Annals of Occupational Hygiene 2009;53(4):307-9. Editorial PubMed · Publisher
• Ford, General Motors, Chrysler, asbestos, and a "sane appreciation of the risks". D. Egilman. International Journal of Occupational and Environmental Health 2009;15(1):109-10. Editorial PubMed · Publisher
• Trends and challenges in treatment of malignant pleural mesothelioma. A. Tsiouris, A. Kourliouros, E.J. Smith. British Journal of Hospital Medicine 2009;70(6):312-3. Editorial PubMed · Publisher
• Airborne environmental exposure to asbestos. A. Hansell. American Journal of Respiratory and Critical Care Medicine 2008;178(6):556-7. Comment · Editorial PubMed · Publisher
• Asbestos mortality: a Canadian export. A. Attaran, D.R. Boyd, M.B. Stanbrook. CMAJ 2008;179(9):871-4. In English, French. Editorial PubMed · Publisher · Free full text
• Asbestos panelists accuse government of misusing science. L. Eggertson. CMAJ 2008;179(9):886-7. News PubMed · Publisher · Free full text
• Asbestos, mesothelioma and the legacy of shipbuilding in Belfast. P.J. Morrison. The Ulster Medical Journal 2008;77(3):145. Comment · Editorial · Historical article PubMed · Free full text
• Asbestos-related disease--a preventable burden. Lancet 2008;372(9654):1927. Editorial PubMed · Publisher
• Asbestos-related diseases: time for technology sharing. K. Takahashi, Asian Asbestos Initiative. Occupational Medicine 2008;58(6):384-5. Editorial PubMed · Publisher · Free full text
• Canada, chrysotile and cancer: Health Canada's Asbestos International Expert Panel report. L.T. Stayner. Journal of Occupational and Environmental Medicine 2008;50(12):1327-8. Editorial PubMed · Publisher
• Canada, chrysotile, and the search for truth. T. Ogden. The Annals of Occupational Hygiene 2008;52(8):673-4. Editorial PubMed · Publisher
• Canadian academics call for asbestos report to be published. D. Spurgeon. BMJ 2008;336(7656):1269. News PubMed · Publisher · Free full text
• Health advocates assail Canada's asbestos stance. R. Collier. CMAJ 2008;179(12):1257. News PubMed · Publisher · Free full text
• International symposium on the health hazard evaluation of fibrous particles associated with taconite and the adjacent duluth complex. Introduction. R.P. Nolan. Regulatory Toxicology and Pharmacology 2008;52(1 Suppl):S4. Editorial PubMed · Publisher
• Iron homeostasis in the lung following asbestos exposure. A.J. Ghio, J. Stonehuerner, J. Richards, et al. Antioxidants & Redox Signaling 2008;10(2):371-7. News PubMed · Publisher
• Professional exposure to carcinogenic substances: is occupational physicians' activity compatible with medical ethics and deontology?. B. Clin, M. Letourneux, G. Launoy. Occupational and Environmental Medicine 2008;65(9):577-8. Editorial PubMed · Publisher
• Screening for mesothelioma: more harm than good?. J.P. van Meerbeeck, G. Hillerdal. American Journal of Respiratory and Critical Care Medicine 2008;178(8):781-2. Comment · Editorial PubMed · Publisher
• Thinking longitudinally in a cross-sectional world. G.R. Wagner. American Journal of Respiratory and Critical Care Medicine 2008;177(6):565-6. Comment · Editorial PubMed · Publisher
• Why study asbestos?. T.L. Guidotti. Archives of Environmental & Occupational Health 2008;63(3):99-100. Editorial PubMed · Publisher
• Asbestos and public health policy in Brazil. R. Mendes. Cadernos de Saúde Pública 2007;23(7):1508-9. In English, Portuguese. Editorial PubMed · Publisher
• Asbestos update. L. Reinstein, L. Kazan-Allen. American Journal of Industrial Medicine 2007;50(1):73-5. Editorial PubMed · Publisher
• Asbestos: immoral fiber, licentious interests. C. Levenstein. New Solutions 2007;17(4):275-8. Editorial PubMed · Publisher
• Environmental asbestos contamination: What are the risks?. V.L. Roggli. Chest 2007;131(2):336-8. Comment · Editorial PubMed · Publisher
• In Australia, patients and government at odds over mesothelioma treatment costs. V. Burkitt. Journal of the National Cancer Institute 2007;99(23):1750-2. News PubMed · Publisher
• Investigating cancer risks related to asbestos and other occupational carcinogens. J. Siemiatycki. Occupational and Environmental Medicine 2007;64(8):500-1. Editorial PubMed · Publisher · Free full text
• Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases. B.T. Mossman, P.J. Borm, V. Castranova, et al. Particle and Fibre Toxicology 2007;4:4. Editorial PubMed · Publisher · Free full text
• Policy: chrysotile on ice. R. Renner. Environmental Health Perspectives 2007;115(3):A130. News PubMed · Publisher · Free full text
• Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for. G.A. Silvestri. The European Respiratory Journal 2007;29(1):6-7. Comment · Editorial PubMed · Publisher
• Shipyard workers and asbestos: a persistent and international problem. W.S. Beckett. Occupational and Environmental Medicine 2007;64(10):639-41. Comment · Editorial PubMed · Publisher · Free full text
• The "Helsinki criteria" for attribution of lung cancer to asbestos exposure: how robust are the criteria?. A. Gibbs, R.L. Attanoos, A. Churg, et al. Archives of Pathology & Laboratory Medicine 2007;131(2):181-3. Editorial · Review PubMed · Publisher
• Treatment of nonmalignant asbestos-related diseases. M.R. Harbut. American Journal of Industrial Medicine 2007;50(1):71-2. Editorial PubMed · Publisher
• Malignant mesothelioma: A disease that continues to mystify. D. Bendayan, M.R. Kramer. The Israel Medical Association Journal 2006;8(7):501-2. Comment · Editorial PubMed
• Asbestos company is forced to fund compensation shortfall. B. Burton. BMJ 2005;330(7482):62. News PubMed · Publisher · Free full text
• Can exposure to very low levels of asbestos induce pleural mesothelioma?. M. Goldberg, D. Luce. American Journal of Respiratory and Critical Care Medicine 2005;172(8):939-40. Comment · Editorial · Review PubMed · Publisher
• Collegium Ramazzini call for an international ban on asbestos. P.J. Landrigan, M. Soffritti. American Journal of Industrial Medicine 2005;47(6):471-4. Editorial PubMed · Publisher
• Collegium Ramazzini statement on the Tokyo Declaration banning asbestos. P.J. Landrigan, M. Soffritti. American Journal of Industrial Medicine 2005;48(2):89-90. Editorial PubMed · Publisher
• Division for Planetary Sciences meeting: Martian methane: rocky birth, then gone with the wind?. G. Schilling. Science 2005;309(5743):1984-5. News PubMed · Publisher
• Serum osteopontin levels--is it time to screen asbestos-exposed workers for pleural mesothelioma?. M.R. Cullen. The New England Journal of Medicine 2005;353(15):1617-8. Comment · Editorial PubMed · Publisher
• Asbestos exposure and lung cancer. C.S. Lee, W.A. Cooper. Pathology 2004;36(6):513-4. Comment · Editorial PubMed · Publisher
• Criminal investigation follows report on asbestos compensation fund. B. Burton. BMJ 2004;329(7469):762. News PubMed · Publisher · Free full text
• Fund for patients with asbestos induced diseases may run out. B. Burton. BMJ 2004;328(7442):728. News PubMed · Publisher · Free full text
• Imaging in staging of malignant pleural mesothelioma. M.T. Truong, R.F. Munden. Cancer Imaging 2004;4(2):95-6. Editorial PubMed · Publisher · Free full text
• Radical surgery for mesothelioma. T. Treasure, D. Waller, S. Swift, et al. BMJ 2004;328(7434):237-8. Editorial PubMed · Publisher · Free full text
• Warning auto mechanics about asbestos hazards. J. LaDou. International Journal of Occupational and Environmental Health 2004;10(1):108-9. Editorial PubMed · Publisher
• Asbestos bodies: clues to the mechanism of asbestos toxicity?. A.B. Kane. Human Pathology 2003;34(8):735-6. Comment · Editorial PubMed · Publisher
• Asbestos investigation under way. R. Renner. Environmental Science & Technology 2003;37(23):426A-428A. News PubMed · Publisher
• Asbestos poisoning was covered up by doctors, claims health team. G. Mudur. BMJ 2003;327(7409):248. News PubMed · Publisher · Free full text
• Asbestos: old foe in 21st century developing countries. L.V. Harris, I.A. Kahwa. The Science of the Total Environment 2003;307(1-3):1-9. Editorial PubMed · Publisher
• Radical surgery for mesothelioma: how can we obtain evidence?. T. Treasure, S. Swift, C. Tan. World Journal of Surgery 2003;27(8):891-4. Editorial PubMed · Publisher
• Additional techniques in serous effusions. A.G. Hanselaar. Analytical Cellular Pathology 2002;24(1):1-4. Comment · Editorial · Review PubMed · Publisher · Free full text
• Criteria for attributing lung cancer to asbestos exposure. P.T. Cagle. American Journal of Clinical Pathology 2002;117(1):9-15. Comment · Editorial PubMed · Publisher
• Mind and matter: OEM and the World Trade Center. H.M. Kipen, M. Gochfeld. Occupational and Environmental Medicine 2002;59(3):145-6. Editorial PubMed · Publisher · Free full text
• Women and mesothelioma. D.D. Smith. Chest 2002;122(6):1885-6. Comment · Editorial PubMed · Publisher
• A ban on asbestos: is now the time?. CMAJ 2001;164(4):453, 455. In English, French. Comment · Editorial PubMed · Free full text
• Apoptosis and asbestos-induced disease: Is there a connection?. V.C. Broaddus. The Journal of Laboratory and Clinical Medicine 2001;137(5):314-5. Comment · Editorial PubMed · Publisher
• Detailed occupational history: the cornerstone in diagnosis of asbestos-related lung disease. R. Bégin, J.W. Christman. American Journal of Respiratory and Critical Care Medicine 2001;163(3 Pt 1):598-9. Comment · Editorial PubMed · Publisher
• Peritoneal mesothelioma proposal for a staging system. G. Sebbag, P.H. Sugarbaker. European Journal of Surgical Oncology 2001;27(3):223-4. Editorial PubMed · Publisher
• WTO upholds French ban on chrysotile. L.K. Allen. International Journal of Occupational and Environmental Health 2001;7(3):246-53. Editorial PubMed · Publisher
• Chrysotile asbestos: why should a carcinogen remain in demand?. S. Chaturvedi. Indian Journal of Public Health 2000;44(3):71-4. Editorial PubMed
• Environmental dangers: asbestos and tuberculosis. G. Hillerdal. Respiration; International Review of Thoracic Diseases 2000;67(2):134. Editorial PubMed · Publisher
• Malignant mesothelioma: predictors of prognosis and clinical trials. J.P. Steele, R.M. Rudd. Thorax 2000;55(9):725-6. Comment · Editorial PubMed · Publisher · Free full text
• Malignant pleural mesotheliomas: an environmental health risk in southeast Turkey. K.M. Müller, M. Fischer. Respiration; International Review of Thoracic Diseases 2000;67(6):608-9. Editorial · Comment PubMed · Publisher
• Mesothelial proliferations. An increasing morphologic spectrum. M.R. Wick, S.E. Mills. American Journal of Clinical Pathology 2000;113(5):619-22. Comment · Editorial · Review PubMed · Publisher

1990s

• Asbestos exposure, asbestosis, and lung cancer. D.E. Banks, M.L. Wang, J.E. Parker. Chest 1999;115(2):320-2. Comment · Editorial PubMed · Publisher
• Asbestos--the legacy lives on. D. Bonn. Lancet 1999;353(9161):1336. News PubMed · Publisher
• Call for an international ban on asbestos. C. Ramazzini. Journal of Occupational and Environmental Medicine 1999;41(10):830-2. Editorial PubMed · Publisher
• Global corporate policies and international "double standards" in occupational and environmental health. B. Castleman. International Journal of Occupational and Environmental Health 1999;5(1):61-4. Editorial PubMed · Publisher
• Medical research in the Rhondda valleys. H.F. Thomas. Postgraduate Medical Journal 1999;75(883):257-9. Editorial · Historical article PubMed · Publisher · Free full text
• Asbestos--still a carcinogen. P.J. Landrigan. The New England Journal of Medicine 1998;338(22):1618-9. Comment · Editorial PubMed · Publisher
• Diagnosing malignant pleural mesothelioma. A.S. Teirstein. Chest 1998;114(3):666-7. Editorial · Comment PubMed · Publisher
• Globally asbestos-free automobiles. B. Castleman. International Journal of Occupational and Environmental Health 1998;4(4):277-8. Editorial · Review PubMed · Publisher
• The diagnosis of desmoplastic malignant mesothelioma. T.V. Colby. American Journal of Clinical Pathology 1998;110(2):135-6. Comment · Editorial PubMed · Publisher
• Unfinished business: the asbestos textiles mystery. J.C. McDonald. The Annals of Occupational Hygiene 1998;42(1):3-5. Editorial · Review PubMed · Publisher
• Asbestos, ergot drugs and the pleura. P. De Vuyst, P. Pfitzenmeyer, P. Camus. The European Respiratory Journal 1997;10(12):2695-8. Comment · Editorial · Review PubMed · Publisher
• Asbestos, the mesothelial cell and malignancy: a matter of life or death. V.C. Broaddus. American Journal of Respiratory Cell and Molecular Biology 1997;17(6):657-9. Comment · Editorial PubMed · Publisher
• Asbestos--a continuing concern. A. Karjalainen. Scandinavian Journal of Work, Environment & Health 1997;23(2):81-2. Editorial PubMed · Publisher
• Battling over asbestos in the third world. Environmental Health Perspectives 1997;105(11):1178-80. News PubMed · Publisher · Free full text
• Canada and France fall out over the risks of asbestos. D. Butler, D. Spurgeon. Nature 1997;385(6615):379. News PubMed · Publisher
• French agency agrees to publication of asbestos report. D. Butler. Nature 1997;390(6657):209. News PubMed · Publisher
• French ministries in argument over release of asbestos report. D. Butler. Nature 1997;389(6652):649-50. News PubMed · Publisher
• Gene transfer and thoracic surgery: more to come. L.R. Kaiser, S.M. Albelda. The Annals of Thoracic Surgery 1997;63(6):1527-8. Comment · Editorial PubMed · Publisher
• Increasing role of immunopathology in diagnosis of malignant mesothelioma. K. Sheibani. Human Pathology 1997;28(6):639-40. Comment · Editorial PubMed · Publisher
• Magic, menace, myth and malice. F.D. Liddell. The Annals of Occupational Hygiene 1997;41(1):3-12. Comment · Editorial · Historical article PubMed · Publisher
• The aetiology of mesothelioma: are risk factors other than asbestos exposure important?. R. Hubbard. Thorax 1997;52(6):496-7. Editorial PubMed · Publisher · Free full text
• 'Natural' cancer prevention trial halted. K. Peterson. Science 1996;271(5248):441. News PubMed · Publisher
• Beta carotene fails to prevent cancer in two major studies; CARET intervention stopped. K. Smigel. Journal of the National Cancer Institute 1996;88(3-4):145. News PubMed · Publisher
• The amphibole hypothesis of asbestos-related cancer--gone but not forgotten. M.R. Cullen. American Journal of Public Health 1996;86(2):158-9. Editorial PubMed · Publisher · Free full text
• French minister promises action to clean up asbestos. A. Dorozynski. BMJ 1995;311(7010):898. News PubMed · Publisher
• OV632 as a possible marker for malignant mesothelioma: high expectations; low specificity. A. Abati, P.A. Fetsch. Diagnostic Cytopathology 1995;12(1):81-2. Editorial PubMed · Publisher
• Editor's preface to the report of the workshop on health risks associated with chrysotile asbestos. J.M. Ellison. The Annals of Occupational Hygiene 1994;38(4):397-8. Editorial · Historical article PubMed · Publisher
• Exercise impairment in asbestos-induced pleural fibrosis. Is it really just interstitial fibrosis?. E.T. Mannix, W.J. Martin. Chest 1994;105(5):1312-3. Comment · Editorial PubMed · Publisher
• Fiber burden and asbestos-related lung disease: determinants of dose-response relationships. M.R. Becklake, B.W. Case. American Journal of Respiratory and Critical Care Medicine 1994;150(6 Pt 1):1488-92. Editorial · Review PubMed · Publisher
• Gasoline, asbestos, and dioxin. Environmental Health Perspectives 1994;102(2):146-7. News PubMed · Free full text
• Immunopathology of malignant mesothelioma. K. Sheibani. Human Pathology 1994;25(3):219-20. Comment · Editorial PubMed · Publisher
• Is malignant mesothelioma being overdiagnosed?. H.J. Sobel. Ultrastructural Pathology 1994;18(3):iii-iv. Editorial PubMed · Publisher
• Media and science: harmless dioxin, benign CFCs, and good asbestos. D.P. Rall. Environmental Health Perspectives 1994;102(1):10. Editorial PubMed · Publisher · Free full text
• Mechanisms of asbestos carcinogenesis and toxicity: the amphibole hypothesis revisited. B.T. Mossman. British Journal of Industrial Medicine 1993;50(8):673-6. Editorial PubMed · Publisher · Free full text
• The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. L.M. Weiss, H. Battifora. Human Pathology 1993;24(4):345-6. Comment · Editorial PubMed · Publisher
• Various aspects of asbestos exposure. W.T. Miller. Seminars in Roentgenology 1992;27(2):81. Editorial PubMed · Publisher
• Analysis of lung asbestos content. A. Churg. British Journal of Industrial Medicine 1991;48(10):649-52. Editorial PubMed · Publisher · Free full text
• Asbestos related malignancy and the Cairns hypothesis. K. Browne. British Journal of Industrial Medicine 1991;48(2):73-6. Editorial PubMed · Publisher · Free full text
• Asbestos: the turbulent interface between science and policy. D.V. Bates. CMAJ 1991;144(5):554-6. Editorial PubMed · Free full text
• Common sense in the environment. Nature 1991;353(6347):779-80. Editorial PubMed · Publisher
• Facts or fears: the need for appropriate responses. A.C. Kolbye. Regulatory Toxicology and Pharmacology 1991;13(2):115. Editorial PubMed · Publisher
• No meeting of the minds on asbestos. R. Stone. Science 1991;254(5034):928-31. News PubMed · Publisher
• The diagnosis of asbestosis. R.N. Jones. The American Review of Respiratory Disease 1991;144(3 Pt 1):477-8. Comment · Editorial PubMed · Publisher
• The progression of panels. M. Greenberg. American Journal of Industrial Medicine 1991;19(1):1-2. Editorial PubMed · Publisher
• Asbestos diseases and compensation. A. Seaton. BMJ 1990;301(6750):453-4. Editorial PubMed · Publisher · Free full text
• Low-level asbestos--the priorities are wrong. D. Ferguson. The Medical Journal of Australia 1990;152(12):617-8. Editorial PubMed · Publisher
• The asbestos removal fiasco. P.H. Abelson. Science 1990;247(4946):1017. Editorial PubMed · Publisher
• The cigarette factor in asbestosis. W. Weiss. Chest 1990;97(4):769-70. Editorial · Comment PubMed · Publisher

1980s

• High-resolution CT in the diagnosis of asbestos-related pleuroparenchymal disease. G. Gamsu. American Journal of Industrial Medicine 1989;16(2):115-7. Editorial PubMed · Publisher
• Shrinking pleuritis with atelectasis. L. Dernevik. American Journal of Industrial Medicine 1989;16(4):451-4. Editorial PubMed · Publisher
• Benign asbestos pleural effusions. Lancet 1988;1(8595):1145-6. Editorial PubMed
• Inorganic dust pneumoconioses. S.D. Rockoff, E. Kagan. Journal of Thoracic Imaging 1988;3(4):vii. Editorial PubMed
• The use of CT in the examination of asbestos-exposed persons. T.C. McLoud. Radiology 1988;169(3):862-3. Editorial PubMed · Publisher
• Asbestos blues. C.E. Rossiter. The Medical Journal of Australia 1987;147(4):162-3. Editorial PubMed · Publisher
• Diagnosis of asbestos-related disease. H. Weill. Chest 1987;91(6):802-3. Editorial PubMed · Publisher
• Friable asbestos in schools must be found by May 1988, removal plan must start by 1989. K. Garrahan. JAMA 1987;257(12):1570-1. News PubMed · Publisher
• Mesothelioma: has patient had contact with even small amount of asbestos?. K. Garrahan. JAMA 1987;257(12):1569-70. News PubMed
• Asbestos examinations for construction workers: a workable alternative. M.D. Whorton. American Journal of Public Health 1986;76(12):1388-9. Editorial PubMed · Publisher · Free full text
• Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers?. K. Browne. British Journal of Industrial Medicine 1986;43(3):145-9. Editorial · Review PubMed · Publisher · Free full text
• Mineral fibres and mesothelioma. J.C. Wagner, F.D. Pooley. Thorax 1986;41(3):161-6. Editorial PubMed · Publisher · Free full text
• Predicting the risks from asbestos. Lancet 1986;1(8487):954. Editorial PubMed
• Asbestos-related disease without asbestosis--why not pleural asbestosis?. T. Beritić, S. Kovac. American Journal of Industrial Medicine 1985;8(6):517-20. Editorial PubMed · Publisher
• Immune responses in asbestos-exposed individuals. D.L. Morris, S.D. Greenberg, E.C. Lawrence. Chest 1985;87(3):278-80. Editorial PubMed · Publisher
• Are all mesotheliomas due to asbestos?. D. Davies. British Medical Journal 1984;289(6453):1164-5. Editorial PubMed · Publisher · Free full text
• Asbestos and the pathologist. Lancet 1984;1(8371):262. Editorial PubMed
• Asbestos related diseases without asbestosis. D. Davies. British Medical Journal 1983;287(6386):164-5. Editorial PubMed · Publisher · Free full text
• Asbestos risks: Manville tries to pass the buck. S. Budiansky. Nature 1983;304(5924):299. News PubMed · Publisher
• Asbestos. Conflicts ahead on UK rules. T. Beardsley. Nature 1983;304(5926):479. News PubMed · Publisher
• Man-made mineral fibres--a safe alternative to asbestos?. Lancet 1983;2(8359):1125. Editorial PubMed
• Tobacco and asbestos: consistent treatment advocated. M. Silverstein, R. Pak, N. Maizlish. Journal of Occupational Medicine. 1983;25(9):694-5. Editorial PubMed · Publisher
• Can society live with asbestos?. D. Gloag. British Medical Journal 1982;284(6331):1728-9. Editorial PubMed · Publisher · Free full text
• Exposure to asbestos and human disease. M.R. Becklake. The New England Journal of Medicine 1982;306(24):1480-2. Editorial PubMed · Publisher
• Mysterious pleural effusions. Lancet 1982;1(8283):1226. Editorial PubMed
• Amosite asbestos and mesothelioma. Lancet 1981;2(8260-61):1397-8. Editorial PubMed
• Asbestos and public health. F.D. Liddell. Canadian Medical Association Journal 1981;125(3):237-9. Editorial PubMed · Free full text
• Asbestos in water. Lancet 1981;2(8238):132. Editorial PubMed
• Asbestos pollution and pleural plaques. The Medical Journal of Australia 1981;1(9):444. Editorial PubMed · Publisher
• Host rocks and gangue minerals in relation to pneumoconiosis and cancer. A.M. Langer. American Journal of Industrial Medicine 1981;2(2):89-90. Editorial PubMed · Publisher
• Smoking, coal, asbestos, and the lungs. British Medical Journal 1981;283(6289):457-8. Editorial PubMed · Free full text
• Asbestos bodies. M.L. Warnock, A.M. Churg. Chest 1980;77(2):129-30. Editorial PubMed · Publisher
• Experts cite paralysis of asbestos exposure control efforts. J. Elliott. JAMA 1980;243(3):211-3, 219. News PubMed · Publisher

1970s

• Asbestos and health. Lancet 1979;2(8148):887. Editorial PubMed
• Asbestos and smoking. I.J. Selikoff, E.C. Hammond. JAMA 1979;242(5):458-9. Editorial PubMed
• Asbestos: killer dust, says book. A. Hay. Nature 1979;281(5728):172. News PubMed · Publisher
• Environmental exposure to asbestos: A factor in the rising rate of cancer in the industrialized world?. M.R. Becklake. Chest 1979;76(3):245-7. Editorial PubMed · Publisher
• Greater public awareness of health hazards of asbestos exposure. Public Health Reports 1979;94(4):388-9. News PubMed · Free full text
• UK to tighten asbestos controls. A. Hay. Nature 1979;282(5734):5. News PubMed · Publisher
• Awkward medicolegal problems in asbestos workers. A.J. Robertson. Journal of the Royal Society of Medicine 1978;71(12):864. Editorial PubMed · Publisher · Free full text
• Lung cancer in shipyard workers: a plea for prevention. E.L. Wynder. The New England Journal of Medicine 1978;299(12):651-2. Editorial PubMed · Publisher
• Proposals on asbestos. Lancet 1978;1(8076):1243. Editorial PubMed
• Risks of environmental exposure to asbestos. British Medical Journal 1978;1(6121):1164-5. Editorial PubMed · Publisher · Free full text
• Asbestos. Lancet 1977;2(8050):1211-2. Editorial PubMed
• The hazard of asbestos. The Medical Journal of Australia 1976;2(16):588-90. Editorial PubMed · Publisher

Browse every journal in the library or other types of article.